JP2005511538A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511538A5
JP2005511538A5 JP2003536265A JP2003536265A JP2005511538A5 JP 2005511538 A5 JP2005511538 A5 JP 2005511538A5 JP 2003536265 A JP2003536265 A JP 2003536265A JP 2003536265 A JP2003536265 A JP 2003536265A JP 2005511538 A5 JP2005511538 A5 JP 2005511538A5
Authority
JP
Japan
Prior art keywords
isomer
mixture
day
isomeric
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003536265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511538A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2002/001560 external-priority patent/WO2003033527A2/en
Publication of JP2005511538A publication Critical patent/JP2005511538A/ja
Publication of JP2005511538A5 publication Critical patent/JP2005511538A5/ja
Withdrawn legal-status Critical Current

Links

JP2003536265A 2001-10-19 2002-10-17 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用 Withdrawn JP2005511538A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34620101P 2001-10-19 2001-10-19
PCT/CA2002/001560 WO2003033527A2 (en) 2001-10-19 2002-10-17 Cyclosporine analogue mixtures and their use as immunomodulating agents

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2009140608A Division JP5272140B2 (ja) 2001-10-19 2009-06-11 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2010151859A Division JP2011006417A (ja) 2001-10-19 2010-07-02 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用

Publications (2)

Publication Number Publication Date
JP2005511538A JP2005511538A (ja) 2005-04-28
JP2005511538A5 true JP2005511538A5 (https=) 2006-01-12

Family

ID=23358378

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2003536265A Withdrawn JP2005511538A (ja) 2001-10-19 2002-10-17 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2009140608A Expired - Lifetime JP5272140B2 (ja) 2001-10-19 2009-06-11 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2010151859A Pending JP2011006417A (ja) 2001-10-19 2010-07-02 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用
JP2013017448A Pending JP2013136597A (ja) 2001-10-19 2013-01-31 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2009140608A Expired - Lifetime JP5272140B2 (ja) 2001-10-19 2009-06-11 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2010151859A Pending JP2011006417A (ja) 2001-10-19 2010-07-02 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用
JP2013017448A Pending JP2013136597A (ja) 2001-10-19 2013-01-31 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用

Country Status (38)

Country Link
US (2) US20110092669A1 (https=)
EP (2) EP1816138A1 (https=)
JP (4) JP2005511538A (https=)
KR (1) KR100992850B1 (https=)
CN (1) CN100344648C (https=)
AR (1) AR036853A1 (https=)
AT (1) ATE401339T1 (https=)
AU (1) AU2002331510B2 (https=)
BE (1) BE2022C547I2 (https=)
BR (1) BR0213659A (https=)
CA (2) CA2727642C (https=)
CO (1) CO5570682A2 (https=)
CY (2) CY1108410T1 (https=)
DE (1) DE60227686D1 (https=)
DK (1) DK1436322T3 (https=)
EC (3) ECSP045061A (https=)
ES (1) ES2310604T3 (https=)
FI (1) FIC20220041I1 (https=)
FR (1) FR22C1051I2 (https=)
HR (1) HRP20040353B1 (https=)
IL (2) IL160762A0 (https=)
LT (1) LTC1436322I2 (https=)
MA (1) MA26337A1 (https=)
ME (1) ME00487B (https=)
MX (1) MXPA04003624A (https=)
MY (1) MY187182A (https=)
NL (1) NL301200I2 (https=)
NO (2) NO331745B1 (https=)
NZ (1) NZ531945A (https=)
PL (1) PL210697B1 (https=)
PT (1) PT1436322E (https=)
PY (2) PY0225477A (https=)
RU (1) RU2337106C2 (https=)
SI (1) SI1436322T1 (https=)
TN (1) TNSN04069A1 (https=)
UY (1) UY27502A1 (https=)
WO (1) WO2003033527A2 (https=)
ZA (1) ZA200402270B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141648B2 (en) 2001-10-19 2006-11-28 Isotechnika Inc. Synthesis of cyclosporin analogs
EP1816138A1 (en) * 2001-10-19 2007-08-08 Isotechnika,Inc. Cyclosporine analogue mixtures and their use as immunomodulating agents
EP1603512A2 (en) 2003-03-17 2005-12-14 Albany Molecular Research, Inc. Novel cyclosporins
TW200505946A (en) * 2003-04-08 2005-02-16 Hoffmann La Roche Process for preparation of cyclosporin a analog
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
WO2006039164A2 (en) 2004-09-29 2006-04-13 Amr Technology, Inc. Novel cyclosporin analogues and their pharmaceutical uses
WO2006041631A2 (en) 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
JP2008524122A (ja) * 2004-12-17 2008-07-10 イソテクニカ インコーポレーテッド シクロスポリン類似体の代謝体
KR101273681B1 (ko) * 2005-10-26 2013-06-25 아스텔라스세이야쿠 가부시키가이샤 신규 시클릭 펩티드 화합물
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
AU2008250254B2 (en) * 2007-05-02 2012-08-16 Astellas Pharma Inc. New cyclic peptide compounds
ES2667945T3 (es) 2007-10-08 2018-05-16 Aurinia Pharmaceuticals Inc. Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
EP2440185B1 (en) 2009-06-09 2015-04-08 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
WO2012079172A1 (en) 2010-12-15 2012-06-21 Isotechnika Pharma Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
GB201222455D0 (en) 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
JP2020510249A (ja) * 2016-11-30 2020-04-02 シュレーディンガー インコーポレイテッドSchrodinger,Inc. 化学の遷移状態を計算するためのグラフィカルユーザインタフェース
US10610104B2 (en) 2016-12-07 2020-04-07 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
WO2018106928A1 (en) 2016-12-08 2018-06-14 Contravir Pharmaceuticals, Inc. Treatment and prevention of hbv diseases by cyclosporine analogue molecules modified at amino acides 1 and 3
EP3554346B1 (en) 2016-12-14 2024-01-31 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with an immunosuppressant
US10286036B2 (en) * 2017-05-12 2019-05-14 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
IL296586B1 (en) 2020-03-26 2026-04-01 Farsight Medical Tech Shanghai Co Ltd Cyclophilin inhibitors and their uses
EP4201952A1 (en) 2021-12-21 2023-06-28 Curia Spain, S.A.U. Process for the controlled synthesis of voclosporin
WO2024052941A1 (en) * 2022-09-09 2024-03-14 Dr. Reddy's Laboratories Limited Improved process for the preparation of voclosporin
IT202300001116A1 (it) * 2023-01-25 2024-07-25 Indena Spa Processo per la preparazione di un intermedio utile per la sintesi di voclosporina
IT202300001056A1 (it) * 2023-01-25 2024-07-25 Procos Spa Nuovo processo per la preparazione di voclosporina amorfa
WO2025119925A1 (en) 2023-12-05 2025-06-12 Medichem, S.A. Process for preparing voclosporin
IT202300028041A1 (it) * 2023-12-27 2025-06-27 Indena Spa Processo per la preparazione di voclosporina

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278545A (en) * 1979-09-12 1981-07-14 The Bendix Corporation Apparatus for separating solids and liquid components
CH670644A5 (https=) * 1986-12-18 1989-06-30 Lonza Ag
US5162540A (en) * 1986-12-18 1992-11-10 Lonza Ltd. Process for the production of (+) biotin
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
US5972630A (en) * 1991-08-19 1999-10-26 Dade Behring Marburg Gmbh Homogeneous immunoassays using enzyme inhibitors
GB9204466D0 (en) * 1992-03-02 1992-04-15 Sandoz Ltd Improvements in or relating to organic compounds
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
CN1494920A (zh) * 1996-06-19 2004-05-12 ��˹��ŵ�� 含有环孢菌素的软胶囊制剂
US5939406A (en) * 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
EP0991660B8 (en) * 1997-10-08 2006-04-05 Isotechnika,Inc. DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
EP1816138A1 (en) * 2001-10-19 2007-08-08 Isotechnika,Inc. Cyclosporine analogue mixtures and their use as immunomodulating agents
US7141648B2 (en) * 2001-10-19 2006-11-28 Isotechnika Inc. Synthesis of cyclosporin analogs

Similar Documents

Publication Publication Date Title
JP2005511538A5 (https=)
RU2337106C2 (ru) Смесь аналогов циклоспорина и ее применение в качестве иммуномодулирующего агента
JP3942641B2 (ja) サイクロスポリンaおよび40―o―(2―ヒドロキシエチル)―ラパマイシンを含む移植拒絶、自己免疫疾患または炎症性状態の処置用医薬組成物
JP4917433B2 (ja) 効果的な医薬の使用法及び副作用発現の防御に関する方法
US20240100005A1 (en) Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases
BE1009856A5 (fr) Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
ES2216141T3 (es) Composiciones farmaceuticas de micofenolato con recubrimiento enterico.
JP2019123738A (ja) ジアルキルフマレート含有薬剤調合物
PT2193788E (pt) Composições farmacêuticas compreendendo dióxido de silício coloidal
RU2204387C2 (ru) Фармацевтические композиции
JP4153563B2 (ja) 医薬組成物
JP2023085437A5 (https=)
CN109476705A (zh) 新型环孢菌素衍生物及其用途
JPWO1998037875A1 (ja) 医薬組成物
TW200522975A (en) Pharmaceutical composition for use in the treatment of an inflammatory autoimmune disease or condition
CN100427097C (zh) 霉酚酸、其盐或前体药物的胃肠外制剂
JP4609877B2 (ja) 慢性拒絶反応抑制剤
CN109803648A (zh) 可逆保护的硫醇化亲电脂肪酸作为前药
CN113557016A (zh) 衣壳组装调节剂固体配制品
Kuiper et al. Cyclosporine-induced anaphylaxis
JPWO2021044045A5 (https=)
JP2000212080A (ja) 勃起機能不全改善剤
TW200932240A (en) Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
ES2362489T3 (es) Método para usar eficazmente un medicamento y método concerniente a la prevención de efectos secundarios.
JPH11501916A (ja) あるシスチン誘導体の薬理学的使用